Hard to Treat Diseases (Hard to Treat Diseases) EV-to-EBITDA : (As of Jun. 20, 2024)

View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Hard to Treat Diseases's enterprise value is $0.00 Mil. Hard to Treat Diseases does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Hard to Treat Diseases's EV-to-EBITDA at this moment.

The historical rank and industry rank for Hard to Treat Diseases's EV-to-EBITDA or its related term are showing as below:

HTDS's EV-to-EBITDA is not ranked ^*
in the Biotechnology industry.
Industry Median: 8.44
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-20), Hard to Treat Diseases's stock price is $1.0E-5. Hard to Treat Diseases does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Hard to Treat Diseases's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Hard to Treat Diseases EV-to-EBITDA Historical Data

The historical data trend for Hard to Treat Diseases's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases EV-to-EBITDA Chart

Hard to Treat Diseases Annual Data

Trend

EV-to-EBITDA

Hard to Treat Diseases Quarterly Data

EV-to-EBITDA

Competitive Comparison of Hard to Treat Diseases's EV-to-EBITDA

For the Biotechnology subindustry, Hard to Treat Diseases's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hard to Treat Diseases's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hard to Treat Diseases's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Hard to Treat Diseases's EV-to-EBITDA falls into.

Hard to Treat Diseases EV-to-EBITDA Calculation

Hard to Treat Diseases's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	0.000	/
	=

Hard to Treat Diseases (OTCPK:HTDS) EV-to-EBITDA Explanation

Hard to Treat Diseases's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	1.0E-5	/
	=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Hard to Treat Diseases EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Hard to Treat Diseases (Hard to Treat Diseases) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762

Website

http://www.htdsmedical.com

Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases (Hard to Treat Diseases) Headlines

No Headlines